Home Cart Sign in  
Chemical Structure| 2765218-56-0 Chemical Structure| 2765218-56-0

Structure of PY-60
CAS No.: 2765218-56-0

Chemical Structure| 2765218-56-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PY-60 is a small molecule agonist that selectively activates annexin A2 (ANXA2) transcriptional activity (Kd=1.4 μM). By directly binding to ANXA2, PY-60 antagonizes its inhibition of YAP activity, demonstrating potential applications in cancer treatment.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PY-60

CAS No. :2765218-56-0
Formula : C16H15N3O2S
M.W : 313.37
SMILES Code : O=C(C1=NOC(C2=CC=CC=C2)=C1)NCCCC3=NC=CS3
MDL No. :MFCD34474253

Safety of PY-60

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of PY-60

Hippo

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293A cells 10 µM 2 to 24 h At least 16 h of continuous PY-60 exposure was required for maximal induction of YAP transcriptional response. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2305085120.
primary adult human epidermal keratinocytes (HEKa) 10 µM 24 h PY-60 induced a robust YAP-driven transcriptional program, reducing terminal differentiation and apoptosis of keratinocytes and increasing proliferative capacity. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2305085120.
HK-2 cells 10 μM 24 h PY-60 increased the expression of Nrf2, while YAP1 knockdown counteracted the effect of TMP on autophagic flux. Int J Biol Sci. 2025 Jan 13;21(3):1158-1173.
Mouse primary hepatocytes 1.6 µm 6 h PY-60 significantly inhibited H/R-induced apoptosis in RAMP1-KO primary hepatocytes by suppressing YAP phosphorylation. J Clin Transl Hepatol. 2024 Apr 28;12(4):357-370.
NCI-H358 cells 10 µM 24 h To examine the effect of PY-60 on the Hippo pathway, results showed PY-60 increased YAP protein levels and inhibited its phosphorylation Cell Div. 2025 Mar 11;20(1):7.
A-549 cells 10 µM 24 h To examine the effect of PY-60 on the Hippo pathway, results showed PY-60 increased YAP protein levels and inhibited its phosphorylation Cell Div. 2025 Mar 11;20(1):7.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Yucatan mini pig Partial and full thickness wound models Topical application 0.15 wt% gel Every other day for 8 days PY-60 significantly accelerated the closure of partial and full thickness wounds, increasing the thickness of both epidermal and dermal layers. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2305085120.
Mice 70% liver ischemia-reperfusion model in RAMP1-KO mice Intraperitoneal injection 10 mg/kg Single dose, lasting 6 hours PY-60 significantly alleviated liver ischemia-reperfusion injury by inhibiting YAP phosphorylation and reducing hepatocyte apoptosis. J Clin Transl Hepatol. 2024 Apr 28;12(4):357-370.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.19mL

0.64mL

0.32mL

15.96mL

3.19mL

1.60mL

31.91mL

6.38mL

3.19mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories